An observational study in Head and Neck Cancer, sponsored by Eli Lilly and Company. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2012-02-13.
Sponsored by Eli Lilly and Company · Observational
The primary objective of this study is to describe, in detail, patterns of care for head and neck carcinoma patient
2,344 studies on the registry are indexed under Head and Neck Neoplasms; 551 are open to participants now.
This study's planned enrollment of 26,000 is above the median of 100 across 441 observational studies indexed under Head and Neck Neoplasms.
Browse Head and Neck Neoplasms studies →Eli Lilly and Company is the lead sponsor of 2,048 studies on the registry; 140 are open to participants now.
Of its 521 completed or terminated interventional studies of FDA-regulated products, 341 (65%) have results posted.
Counted across the registry records on this site, refreshed daily.
Primary care clinic
Exclusion Criteria:
Other: Therapy for head and neck cancer
radiotherapy and/or drug therapy including chemotherapy, biologic therapy and targeted therapy
Patterns of care for head and neck cancer
Time frame: up to 10 years
Overall survival by treatment regimen
Time frame: study entry to death from any cause or to end of study
Determine the incidence and severity of major dose-limiting and other important treatment toxicities
Time frame: up to 10 years
Identify supportive care received for managing nutrition, pain, nausea and other complications
Time frame: up to 10 years
tumor control by treatment regimen
Time frame: study entry to progressive disease
This study is completed, as verified in Feb 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Eli Lilly and Company